Utilization of Antibiotics for Hospitalized Patients with Severe Coronavirus Disease 2019 in Al-Madinah Al-Munawara, Saudi Arabia: A Retrospective Study

References

• European Centre for Disease Prevention and Control. Rapid risk assessment. Increased transmission of COVID-19 in the EU/EEA and the UK–thirteenth update; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-increased-transmission-thirteenth-update. Accessed June 24, 2022.
   Google Scholar
• Beović B, Doušak M, Ferreira-Coimbra J, et al. Antibiotic use in patients with COVID-19: a ‘snapshot’Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020;75(11):3386–3390. doi:10.1093/jac/dkaa326
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308–1315. doi:10.1001/jamainternmed.2017.1938
   PubMed Web of Science ®Google Scholar
• Courtenay M, Castro-Sanchez E, Fitzpatrick M, Gallagher R, Lim R, Morris G. Tackling antimicrobial resistance 2019–2024–the UK’s five-year national action plan. J Hosp Infect. 2019;101(4):426–427. doi:10.1016/j.jhin.2019.02.019
   Web of Science ®Google Scholar
• Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918–19 influenza pandemic. Emerg Infect Dis. 2008;14(8):1193. doi:10.3201/eid1408.071313
   PubMed Web of Science ®Google Scholar
• Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198(7):962–970. doi:10.1086/591708
   PubMed Web of Science ®Google Scholar
• Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8:1041. doi:10.3389/fmicb.2017.01041
   PubMed Web of Science ®Google Scholar
• Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia. 2021;13(1):1–15. doi:10.1186/s41479-021-00083-w
   Web of Science ®Google Scholar
• Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One. 2009;4(12):e8540. doi:10.1371/journal.pone.0008540
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Chen J. COVID-19 scientific advisory group rapid response report 2020. Alberta Health Services; May 6, 2020.
   Google Scholar
• Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Atlanta, GA: US Department of Health and Human Services; 2013. Available from: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed June 10, 2022.
   Google Scholar
• Kwon WJ, Li G, Zheng M, Kaur H, Magbual N, Dalai S. Superinfections and coinfections in COVID-19–separating the signal from the noise. Medpage Today; 2020;28.
   Google Scholar
• d’Humières C, Patrier J, Lortat-Jacob B, et al. Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France. PLoS One. 2021;16(4):e0250728. doi:10.1371/journal.pone.0250728
   PubMed Web of Science ®Google Scholar
• Rawson TM, Moore LSP, Castro-Sanchez E, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75(7):1681–1684. doi:10.1093/jac/dkaa194
   PubMed Web of Science ®Google Scholar
• Huttner BD, Catho G, Pano-Pardo JR, Pulcini C, Schouten J. COVID-19: don’t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020;26(7):808–810. doi:10.1016/j.cmi.2020.04.024
   PubMed Web of Science ®Google Scholar
• MoH, Saudi. Protocol for Patients Suspected of/Confirmed with COVID-19 Supportive care and antiviral treatment of suspected or confirmed COVID-19 infection. Available from:https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/MOH-therapeutic-protocol. Accessed May 10, 2022.
   Google Scholar
• Memish ZA, Shibl AM, Ahmed QAA; Group SAC-APW. Guidelines for the management of community-acquired pneumonia in Saudi Arabia: a model for the Middle East region. Int J Antimicrob Agents. 2002;20:S1–S12. doi:10.1016/S0924-8579(02)00243-1
   Web of Science ®Google Scholar
• Mustafa L, Tolaj I, Baftiu N, Fejza H. Use of antibiotics in COVID-19 ICU patients. J Infect Dev Ctries. 2021;15(4):501–505. doi:10.3855/jidc.14404
   Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Instituto Superiore Di Sanita. COVID-19 surveillance group. Characteristics of COVID-19 patients dying in Italy: report based on available data on March 20th, 2020. Epidemiology for public health Istituto Superiore di Sanità; January 10, 2022. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdf. Accessed June 27, 2022.
   Google Scholar
• Smati S, Tramunt B, Wargny M, et al. Relationship between obesity and severe COVID‐19 outcomes in patients with type 2 diabetes: results from the CORONADO study. Diabetes Obes Metab. 2021;23(2):391–403. doi:10.1111/dom.14228
   PubMed Web of Science ®Google Scholar
• Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020;71(15):896–897. doi:10.1093/cid/ciaa415
   PubMed Web of Science ®Google Scholar
• Anderson MR, Geleris J, Anderson DR, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020;173(10):782–790. doi:10.7326/M20-3214
   PubMed Web of Science ®Google Scholar
• Miranda C, Silva V, Capita R, Alonso-Calleja C, Igrejas G, Poeta P. Implications of antibiotics use during the COVID-19 pandemic: present and future. J Antimicrob Chemother. 2020;75(12):3413–3416. doi:10.1093/jac/dkaa350
   PubMed Web of Science ®Google Scholar
• Dudoignon E, Caméléna F, Deniau B, et al. Bacterial pneumonia in COVID-19 critically ill patients: a case series. Clin Infect Dis. 2021;72(5):905–906. doi:10.1093/cid/ciaa762
   Web of Science ®Google Scholar
• Metlay JP, Waterer GW. Treatment of community-acquired pneumonia during the coronavirus disease 2019 (COVID-19) pandemic. Ann Intern Med. 2020;173(4):304–305. doi:10.7326/M20-2189
   PubMed Web of Science ®Google Scholar
• Stevens MP, Patel PK, Nori P. Involving antimicrobial stewardship programs in COVID-19 response efforts: all hands on deck. Infect Control Hosp Epidemiol. 2020;41(6):744–745. doi:10.1017/ice.2020.69
   PubMed Web of Science ®Google Scholar
• Spernovasilis NA, Kofteridis DP. COVID-19 and antimicrobial stewardship: what is the interplay? Infect Control Hosp Epidemiol. 2021;42(3):378–379. doi:10.1017/ice.2020.246
   Web of Science ®Google Scholar
• Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26(10):1395–1399. doi:10.1016/j.cmi.2020.06.025
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect s. 2020;26(12):1622–1629. doi:10.1016/j.cmi.2020.07.016
   PubMed Web of Science ®Google Scholar
• Echeverría-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco ME, et al. Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther. 2021;19(2):147–163. doi:10.1080/14787210.2020.1813024
   PubMed Web of Science ®Google Scholar
• Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 2014;143(2):225–245. doi:10.1016/j.pharmthera.2014.03.003
   PubMed Web of Science ®Google Scholar
• Rosenberg ES, Dufort EM, Udo T, et al. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA. 2020;323(24):2493–2502. doi:10.1001/jama.2020.8630
   PubMed Web of Science ®Google Scholar
• Shimizu T, Shimizu S. Azithromycin inhibits mucus hypersecretion from airway epithelial cells. Mediators Inflamm. 2012;2012:265714. doi:10.1155/2012/265714
   PubMed Web of Science ®Google Scholar
• Beigelman A, Mikols CL, Gunsten SP, Cannon CL, Brody SL, Walter MJ. Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis. Respir Res. 2010;11(1):90. doi:10.1186/1465-9921-11-90
   PubMed Web of Science ®Google Scholar
• Martínez JA, Horcajada JP, Almela M, et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2003;36(4):389–395. doi:10.1086/367541
   PubMed Web of Science ®Google Scholar
• Furtado RHM, Berwanger O, Fonseca HA, et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020;396(10256):959–967. doi:10.1016/S0140-6736(20)31862-6
   PubMed Web of Science ®Google Scholar
• Wang X, Kattan MW. Cohort studies: design, analysis, and reporting. Chest. 2020;158(1S):S72–S78. doi:10.1016/j.chest.2020.03.014
   PubMed Web of Science ®Google Scholar